Navigation Links
Michael J. Fox Foundation PD Therapeutics Conference
Date:8/7/2008

The Michael J. Fox Foundation for Parkinson's Research (MJFF) will host its second annual PD Therapeutics Conference on Monday, September 15, in Chicago.

Chaired by Jeffrey Kordower, PhD, Director, Research Center for Brain Repair and Jean-Schweppe Armour Professor of Neurological Sciences at Rush University Medical Center, the conference will bring together academic and industry scientists to focus on novel research advances impacting development of improved disease-modifying and symptomatic interventions for the diagnosis and treatment of PD.

Select MJFF-funded investigators will present research on topics including novel neuroprotective agents, innovative mechanisms to address disease symptoms and improvements in relevant animal models, and biomarker discovery/development.

In addition to scientific talks, a small poster session will highlight novel targets and animal models relevant to PD research.

Confirmed speakers include:

  • D. James Surmeier, PhD (Northwestern University), on the FDA-approved diabetes drug that may protect dopamine neurons in the Parkinson's brain

  • Anders Bjrkund, MD, PhD (Lund University, Sweden), on the role of serotonin (better known for the part it plays in depression) in dyskinesias, the disruptive movements brought on by long-term dopamine replacement therapy

  • Erwan Bezard, PhD (Universite Victor Segalen, Bordeaux, France), and Piu Chan, MD, PhD (Beijing Institute of Geriatrics, China), on conducting pre-clinical and clinical research in China

  • Patrik Brundin, MD, PhD (Lund University, Sweden), on the state of cell replacement approaches for Parkinson's disease

Registration is free for accredited members of the press.

Last year's inaugural conference in New York City drew a multidisciplinary audience of nearly 200 academic, pharmaceutical and biotechnology industry researchers.


'/>"/>

Contact: Holly Barkhymer
hbarkhymer@michaeljfox.org
212-509-0995 x242
The Michael J. Fox Foundation for Parkinson's Research
Source:Eurekalert

Page: 1

Related biology news :

1. [video] Michael DePasquale, CEO of BIO-key International, Inc., Discusses Q2 2008 Revenue Growth on WallSt.nets 3-Minute Press Show
2. Michael J. Fox Foundation Funds $1.1 Million for Cutting-edge Approaches to Parkinsons Disease
3. Michael J. Fox Foundation awards $2.4M for validation of therapeutic targets for Parkinsons
4. Neuroscientist Michael Gazzaniga awarded Humboldt Prize
5. Remarks Prepared for Delivery By Attorney General Michael B. Mukasey At the Ministerial Press Conference
6. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
7. American Society for Microbiology honors Michael Bruce Zwick
8. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
9. W.M. Keck Foundation grant funds reproductive science research
10. W.M. Keck Foundation announces 2008 class of Distinguished Young Scholars in Medical Research
11. Glenn Foundation for Medical Research commits $5 million to study aging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2016)... JOSE, Calif. , Jan. 18, 2016 /PRNewswire/ ... security software that simplifies the use and access ... technology and go-to-market partnership with American Cyber.  ... Cyber brings extensive experience leading transformational C4ISR and ... implementing and integrating the latest proven technology solutions," ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
(Date:1/11/2016)... , Jan. 11, 2016 Synaptics Incorporated ... interface solutions, today announced that its ClearPad ® ... (TDDI) products won two separate categories in the 8 ... Innovator and Best Technology Breakthrough. The Synaptics ® ... a simplified supply chain, thinner devices, brighter displays and ...
Breaking Biology News(10 mins):
(Date:2/12/2016)... , Feb. 12, 2016  PTC Therapeutics, Inc. ... annual STRIVE (Strategies to Realize Innovation, Vision and ... (DMD). STRIVE provides funds to patient advocacy organizations ... make meaningful contributions to the rare disease community ... of future patient advocates. Mary ...
(Date:2/11/2016)... NBIX ) today announced its financial results for the quarter ... --> For the fourth quarter of 2015, the ... per share, compared to a net loss of $19.4 million, or ... the year ended December 31, 2015, the Company reported a net ... to a net loss of $60.5 million, or $0.81 loss per ...
(Date:2/11/2016)... , Feb. 11, 2016  Bioethics International, a not-for-profit organization ... researched, developed, marketed and made accessible to patients around the ... had named the publication of the Good Pharma ... publication is also featured as one of BMJ Open ... last year that are most frequently read. Ed ...
(Date:2/11/2016)... (PRWEB) , ... February 11, ... ... business-to-business publication dedicated to delivering cutting-edge information focused on the development and ... Sciences to become a premier sponsor of the 2016 BioProcess International Awards ...
Breaking Biology Technology: